Lithium and lecithin in tardive dyskinesia: an update
- PMID: 3538109
- DOI: 10.1016/0165-1781(86)90002-8
Lithium and lecithin in tardive dyskinesia: an update
Abstract
Psychiatric inpatients with tardive dyskinesia (TD) were treated with either lithium alone (n = 9) or with a combination of lithium and lecithin (n = 9) for 5 weeks in a double-blind, placebo-controlled experiment. A statistically significant but clinically unimportant improvement of TD occurred during both treatments. The addition of lecithin to lithium had no effect.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
